Slide 1: Annual Shareholders Meeting CEO Update
Annual Shareholders Meeting CEO Update NZX | ASX: TRU September 2022
Slide 2: Our Vision: a world without cervical cancer
os e ge @ oe. ~ Our Vision euis = e e truscreen ~ aworld without cervical cancer @) ~ Cervical cancer can be prevented E During 2022, TruScreen continued to provide a accurate, real-time screening solution, with over aq 170,000 women screened in China, Vietnam, ~- Zimbabwe, Mexico & Saudi Arabia fs)
Slide 3: WHO Global Targets for 2030
The World Health Organisation (WHO) has seta target to eliminate cervical cancer by the end of the century.’ WHO Global Targets for 2030 90% coverage of HPV 70% coverage of Management of 90% of Vaccination of girls screening® and 90% invasive cancer cases (by 15 years of age) treatment of precancero
Slide 4: For personal use only
For personal use only • • • • • • • • • •
Slide 5: For personal use only
For personal use only ⚫ ⚫ ⚫ ⚫ ⚫ ⚫ ⚫
Slide 6: Target
For personal use only 265 195 176 156 81 78 Target
Slide 7: For personal use only
For personal use only
Slide 8: Key Financials
For personal use only KEY FINANCIALS FY 20 FY 21 FY 22 NZD (m) Actual Actual Actual ⚫ ⚫ ⚫
Slide 9: For personal use only
For personal use only ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪
Slide 10: For personal use only
For personal use only * Subject to COVID-19 and geopolitical situation
Slide 11: For personal use only
For personal use only o o o o o o o o o
Slide 12: The Opportunity for TruScreen
The Opportunity for TruScreen acess 80°60 truscreen Improve market access and take advantage of post-COVID opportunities Leverage new strong clinical data that further validates TruScreen technology Barrier to entry to China removed with the addition of Made in China TruScreen device to National Pri
Slide 13: TruScreen's Outlook
TruScreen’s Outlook Driving adoption in key and new markets
Slide 14: For personal use only
For personal use only ● ● ● ● ● ● ● ● ● ● * Subject to cvoid-19 conditions and geopolitical situation.
Slide 15: For personal use only
For personal use only ● ● ● ● ● ● ● ● * Subject to cvoid-19 conditions and geopolitical situation.
Slide 16: For personal use only
For personal use only ● ● ● ● ● ● ● ● ● * Subject to cvoid-19 conditions and geopolitical situation.
Slide 17: For personal use only
For personal use only ⚫ ⚫ ⚫ ⚫ ⚫ * Subject to COVID-19 conditions and geopolitical situation.
Slide 18: References
References WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention, second edition. Geneva: World Health Organization; 2021. Licence: CC BY-NC-SA 3.0 IGO. bttps://www who int/publications/i/item/ 40030824 . WHO, Unitaid, CHAI. Cervical Cancer Screening
Slide 19: Disclaimers
Disclaimers @e@ truscreen This presentation has been prepared by TruScreen Group Limited (the “Company") and is dated 06 September 2022. This presentation contains summary information about the Company and its activities which is current as at the date of this presentation. The information in this p